Literature DB >> 8549486

Age-specific oncogenesis: the genetics of cancer susceptibility.

D Malkin1.   

Abstract

Cancer is considered to be a multifactorial disease in which a host cell is transformed from normal to malignant as a result of complex interactions of external (environmental) stimuli and cancer-predisposing or cancer-suppressing genes. Although certain chemical carcinogens and ionizing radiation are known to cause specific alterations at the level of the gene, other correlations are less clear. Not infrequently, cancer is found to aggregate in families in an apparently nonrandom fashion. It has been through the study of such families that our understanding of the genetic events leading to cancer has developed. Both common and rare tumors may occur together in familial-cancer families. Frequently, tumors occur at an earlier age than one would expect in the general population; often, multiple tumors of different organs develop in a particular affected family member. Recent advances in the genetics of familial cancer syndromes have led to the possibility to perform genetic testing on unaffected relatives who might carry a genetic defect that predisposes them to cancer. Complex ethical, social, and legal implications arise from these new technical advances.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8549486      PMCID: PMC1518926          DOI: 10.1289/ehp.95103s637

Source DB:  PubMed          Journal:  Environ Health Perspect        ISSN: 0091-6765            Impact factor:   9.031


  9 in total

1.  Recommendations on predictive testing for germ line p53 mutations among cancer-prone individuals.

Authors:  F P Li; J E Garber; S H Friend; L C Strong; A F Patenaude; E T Juengst; P R Reilly; P Correa; J F Fraumeni
Journal:  J Natl Cancer Inst       Date:  1992-08-05       Impact factor: 13.506

2.  Soft-tissue sarcomas, breast cancer, and other neoplasms. A familial syndrome?

Authors:  F P Li; J F Fraumeni
Journal:  Ann Intern Med       Date:  1969-10       Impact factor: 25.391

Review 3.  Clinical implications of the p53 tumor-suppressor gene.

Authors:  C C Harris; M Hollstein
Journal:  N Engl J Med       Date:  1993-10-28       Impact factor: 91.245

Review 4.  Cancer risk notification: psychosocial and ethical implications.

Authors:  C Lerman; B K Rimer; P F Engstrom
Journal:  J Clin Oncol       Date:  1991-07       Impact factor: 44.544

5.  Hereditary cancers disclose a class of cancer genes.

Authors:  A G Knudson
Journal:  Cancer       Date:  1989-05-15       Impact factor: 6.860

6.  Follow-up study of twenty-four families with Li-Fraumeni syndrome.

Authors:  J E Garber; A M Goldstein; A F Kantor; M G Dreyfus; J F Fraumeni; F P Li
Journal:  Cancer Res       Date:  1991-11-15       Impact factor: 12.701

7.  Genetic and familial cancer: opportunities for prevention and early detection.

Authors:  F P Li
Journal:  Cancer Detect Prev       Date:  1986

8.  Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms.

Authors:  D Malkin; F P Li; L C Strong; J F Fraumeni; C E Nelson; D H Kim; J Kassel; M A Gryka; F Z Bischoff; M A Tainsky
Journal:  Science       Date:  1990-11-30       Impact factor: 47.728

9.  Germline mutations in the p53 tumour suppressor gene: scientific, clinical and ethical challenges.

Authors:  J M Birch
Journal:  Br J Cancer       Date:  1992-09       Impact factor: 7.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.